Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
| Delaware District Court | |
| Judge: | Gregory B Williams |
| Case #: | 1:25-cv-00563 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:1 Patent Infringement |
| Case Filed: | May 07, 2025 |
| Last checked: Friday May 09, 2025 12:39 AM EDT |
|
Defendant
Alkem Laboratories Ltd.
|
|
|
Plaintiff
Azurity Pharmaceuticals, Inc.
|
Represented By
|
| Docket last updated: 12 hours ago |
| Friday, May 16, 2025 | ||
|
order
SO ORDERED
Fri 05/16 8:09 AM
SO ORDERED, re6 MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Tung-On Kong, Natalie J. Morgan, Emily M. Shingle, and Mark A. Hayden of Wilson Sonsini Goodrich & Rosati P.C. filed by Azurity Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 5/16/2025. (lnb) |
||
| Thursday, May 15, 2025 | ||
| 7 | 7
misc
-District Court Pro Hac Vice Fee - 05 Attorneys Credit Card Payment
Thu 05/15 1:17 PM
Pro Hac Vice Fee - Credit Card Payment received for Wendy L. Devine, Tung-On Kong, Natalie J. Morgan, Emily M. Shingle, and Mark A. Hayden. ( re6 MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Tung-On Kong, Natalie J. Morgan, Emily M. Shingle, and Mark A. Hayden of Wilson Sonsini Goodrich & Rosati P.C. )( Payment of $ 250, receipt number ADEDC-4687544).(Palapura, Bindu) |
|
| 6 | 6
motion
Appear Pro Hac Vice
Thu 05/15 1:14 PM
MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Tung-On Kong, Natalie J. Morgan, Emily M. Shingle, and Mark A. Hayden of Wilson Sonsini Goodrich & Rosati P.C. - filed by Azurity Pharmaceuticals, Inc.. (Palapura, Bindu) |
|
| Wednesday, May 14, 2025 | ||
|
utility
Case Assigned/Reassigned
Wed 05/14 10:56 AM
Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (nmf) |
||
| Thursday, May 08, 2025 | ||
|
service
No Summons Issued
Thu 05/08 8:47 AM
No Summons Issued. (cdd) |
||
| Wednesday, May 07, 2025 | ||
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Thu 05/08 8:47 AM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc.. (cdd) |
|
| 4 | 4
misc
Patent/Trademark Report to Commissioner of Patents
Thu 05/08 8:46 AM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,478,456 B2; 11,529,333 B2. (cdd) |
|
| 3 | 3
misc
ANDA Form
Thu 05/08 8:44 AM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/24/2025. Date of Expiration of Patent: 11,478,456 8/18/2038; 11,529,333 5/21/2039. Thirty Month Stay Deadline: 9/24/2027. (cdd) |
|
| 2 | 2
misc
Magistrate Consent Forms
Thu 05/08 8:40 AM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) |
|
| 1 | 1
10
pgs
cmp
Complaint
Thu 05/08 8:39 AM
COMPLAINT for Patent Infringement against Alkem Laboratories Ltd. (Filing fee $ 405, receipt number ADEDC-4681321) - filed by Azurity Pharmaceuticals, Inc. (cdd) |
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Civil Cover Sheet
|
||